Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Apnea monitor standard should not require back-up modality in hospitals -- SpaceLabs.

This article was originally published in The Gray Sheet

Executive Summary

INFANT APNEA MONITOR SECONDARY MONITORING MODALITY should not be required in hospital settings, SpaceLabs says in comments submitted to FDA May 19 on the agency's proposed infant apnea monitor standard. While the requirement for a back-up monitoring modality "may be appropriate for home use," hospitals often use separate devices for primary and secondary monitoring, the company says. Therefore, "requiring a secondary modality in a hospital setting goes beyond the control of any one device manufacturer."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT004168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel